Results
|
|
3061.
|
|
|
|
3062.
|
|
|
|
3063.
|
|
|
|
3064.
|
|
|
|
3065.
|
|
|
|
3066.
|
|
|
|
3067.
|
Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia. [electronic resource] by
- Lancet, J E
- Gojo, I
- Burton, M
- Quinn, M
- Tighe, S M
- Kersey, K
- Zhong, Z
- Albitar, M X
- Bhalla, K
- Hannah, A L
- Baer, M R
Producer: 20100520
In:
Leukemia vol. 24
Availability: No items available.
|
|
|
3068.
|
Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer. [electronic resource] by
- Song, Dongweon
- Chaerkady, Raghothama
- Tan, Aik Choon
- García-García, Elena
- Nalli, Anuradha
- Suárez-Gauthier, Ana
- López-Ríos, Fernando
- Zhang, Xian Feng
- Solomon, Anna
- Tong, Jeffrey
- Read, Margaret
- Fritz, Christian
- Jimeno, Antonio
- Pandey, Akhilesh
- Hidalgo, Manuel
Producer: 20081112
In:
Molecular cancer therapeutics vol. 7
Availability: No items available.
|
|
|
3069.
|
|
|
|
3070.
|
|
|
|
3071.
|
|
|
|
3072.
|
|
|
|
3073.
|
|
|
|
3074.
|
|
|
|
3075.
|
|
|
|
3076.
|
|
|
|
3077.
|
|
|
|
3078.
|
|
|
|
3079.
|
|
|
|
3080.
|
|